6-碘吡啶-3-羧醛 | 817618-55-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 6-碘吡啶-3-羧醛
• 英文名称: 6-iodopyridine-3-carbaldehyde
• CAS: 817618-55-6
• 化学式: C₆H₄INO
• 分子量: 233.008
• InChiKey: FVXFNWUQVDZJPX-UHFFFAOYSA-N

物化性质

• 沸点：
  298.9±25.0 °C(Predicted)
• 密度：
  2.001±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-碘吡啶-3-羧醛 、 4-(4-二甲基氨基苯基)丁-3-烯-2-酮 在 sodium methylate 作用下， 以 甲醇 、 乙醇 为溶剂， 反应 12.0h， 以32.5%的产率得到(1E,4E)-1-(4-(dimethylamino)phenyl)-5-(6-iodopyridin-3-yl)penta-1,4-dien-3-one
  参考文献：
  名称：

  Synthesis and Structure−Affinity Relationships of Novel Dibenzylideneacetone Derivatives as Probes for β-Amyloid Plaques

  摘要：

  A new and extensive set of dibenzylideneacetone derivatives was synthesized and screened for affinity toward A beta(1-42) aggregates. Structure-activity relationships revealed the binding of dibenzylideneacetones to be affected by various substituents. The introduction of a substituent group in the ortho position reduced or abolished the binding. However, the para position was highly tolerant of sterically demanding substitutions. Three radioiodinated ligands (6, 70, and 71) and two F-18 fluoro-pegylated (FPEG) ligands (83 and 85) were prepared, all of which displayed high affinity folr A beta(1-42) aggregates (K-i ranging from 0.9 to 7.0 nM). In biodistribution experiments, they exhibited good initial penetration (1.59, 4.68, 4.56, 4.13, and 5.15% ID/g, respectively, at 2 min) of and fast clearance from the brain. Autoradiography with sections of postmortem AD brain and transgenic mouse brain confirmed the high affinity of these tracers. These preliminary results strongly suggest the dibenzylideneacetone structure to be a potential new scaffold for beta-amyloid imaging probes.

  DOI：

  10.1021/jm101404k
• 作为产物：
  描述：

  5-(hydroxymethyl)-2-iodopyridine 在 manganese dioxide 水 、 6-碘吡啶-3-羧醛 作用下， 以 二氯甲烷 为溶剂， 反应 20.0h， 以are obtained in the form of a pale yellow solid with a melting point of 141° C.的产率得到6-碘吡啶-3-羧醛
  参考文献：
  名称：

  Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds

  摘要：

  具有以下一般式（I）的新化合物在人类或兽医学中有广泛的应用（在皮肤病学、心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域），或者被制成化妆品配方中。

  公开号：

  US20100247468A1
• 作为试剂：
  描述：

  5-(hydroxymethyl)-2-iodopyridine 在 manganese dioxide 水 、 6-碘吡啶-3-羧醛 作用下， 以 二氯甲烷 为溶剂， 反应 20.0h， 以are obtained in the form of a pale yellow solid with a melting point of 141° C.的产率得到6-碘吡啶-3-羧醛
  参考文献：
  名称：

  Methods of modulating PPAR gamma-type receptors

  摘要：

  具有以下一般式（I）的新型化合物在人类或兽医学中有广泛的应用（在皮肤病学以及心血管疾病、免疫疾病和/或与脂质代谢相关的疾病领域），或者被制成化妆品组合物。

  公开号：

  US08022079B2

文献信息

• NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS
  申请人：Boiteau Jean-Guy

  公开号：US20090012129A1

  公开（公告）日：2009-01-08

  Novel biaromatic compounds that modulate peroxisome proliferator-activator receptors, known as PPAR, having the formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively, in cosmetic compositions.

  将调节过氧化物酶增殖激活受体（PPAR）的新型双芳香化合物配方（I）制成药用组合物，可用于人类或兽医医学，或者用于化妆品组合物。
• [EN] NOVEL COMPOUNDS THAT MODULATE PPARgamma TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS<br/>[FR] NOUVEAUX COMPOSES QUI MODULENT LES RECEPTEURS DE TYPE PPAR DOLLAR G(G) ET UTILISATIONS DE CEUX-CI DANS DES COMPOSITIONS COSMETIQUES OU PHARMACEUTIQUES
  申请人：GALDERMA RES & DEV

  公开号：WO2004113331A1

  公开（公告）日：2004-12-29

  The invention relates to novel compounds corresponding to the general formula (I) below: (I) and also to the method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism),-or alternatively in cosmetic compositions.

  该发明涉及与下列一般式（I）相对应的新化合物：（I），以及用于制备它们的方法，以及它们在用于人类或兽医药物组合物中的用途（在皮肤病学以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域），或者在化妆品组合物中的用途。
• Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
  申请人：Clary Laurence

  公开号：US20060148862A1

  公开（公告）日：2006-07-06

  Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

  具有以下一般式（I）的新化合物在人类或兽医学中具有广泛的应用（在皮肤病学中，以及在心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域），或者被制成化妆品组合物。
• LABELLED ANALOGUES OF HALOBENZAMIDES AS RADIOPHARMACEUTICALS
  申请人：Madelmont Jean-Claude

  公开号：US20100061928A1

  公开（公告）日：2010-03-11

  The present invention relates to the use of a compound of formula (I): in which R 1 represents a radionuclide, Ar represents an aromatic nucleus, m is an integer varying from 2 to 4, R 2 and R 3 represent, independently of one another, a hydrogen atom, a (C 1 -C 6 )alkyl group, a (C 1 -C 6 )alkenyl group or an aryl group chosen from a phenyl, benzyl, imidazolyl, pyridyl, pyrimidinyl, pyrazinyl, indolyl, indazolyl, furyl and thienyl group, and their addition salts with pharmaceutically acceptable acids, in the preparation of a radiopharmaceutical composition intended for the diagnosis and/or treatment of melanoma.

  本发明涉及使用式（I）化合物：其中R1代表放射性核素，Ar代表芳香环，m为2到4的整数，R2和R3代表独立的氢原子，（C1-C6）烷基，（C1-C6）烯基或苯基，所述苯基选择自苯基，苄基，咪唑基，吡啶基，嘧啶基，吡嗪基，吲哚基，吲唑基，呋喃基和噻吩基，并且它们与药学上可接受的酸的加成盐，用于制备放射性药物组合物，用于诊断和/或治疗黑色素瘤。
• METHODS OF MODULATING PPAR GAMMA-TYPE RECEPTORS
  申请人：CLARY Laurence

  公开号：US20100099689A1

  公开（公告）日：2010-04-22

  Novel compounds having the general formula (I) below: are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions.

  具有以下一般式（I）的新化合物在人类或兽医学中具有广泛的应用（在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢相关的疾病领域），或者被制成化妆品组合物。